A Trial to Investigate Efficacy and Usability of Published Best Practice to Control Glycaemia

An Open, Single-centre, Controlled Trial to Investigate the Efficacy and Usability of Published Best Practice to Control Glycaemia in Hospitalised Patients With Type 2 Diabetes

Status

Completed

Phases

Phase 4

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01407289

Enrollment

Registered

2011-08-02

Start date

2011-06-30

Completion date

2012-04-30

Last updated

2013-02-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus, Type 2

Brief summary

The purpose of the study is to compare the efficacy of enhanced published best practice paper-based insulin titration protocol for glycaemic control in hospitalised patients with type 2 diabetes for the length of hospital stay.

Interventions

DRUGInsulin Aspart, Insulin Glargine

The Intervention is a paper based protocol, which provides suggestions for new insulin doses (basal-bolus regime).

Study design

Allocation

NON_RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to 90 Years

Healthy volunteers

Inclusion criteria

* Type 2 diabetes * Blood glucose in the range between 140 - 400 mg/dl * Expected stay ≥ 48 hours

Exclusion criteria

* Hyperglycemia without known history of type 2 diabetes mellitus * Impaired renal function (serum creatinine ≥3.0mg/dL) * Clinically relevant hepatic disease

Design outcomes

Primary

Measure	Time frame	Description
Mean blood glucose	duration of hospital stay (48 hours - maximum three weeks)	Mean blood glucose over 24 hours

Secondary

Measure	Time frame
Number of glucose measurements in hyperglycaemic ranges	duration of hospital stay (48 hours - maximum three weeks)

Countries

Austria

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026